hat
Methandriol pa dirèkteman aromatize pa kò a, byenke youn nan metabolit li yo li te ye se methyltestosterone, sa ki ka aromatize. Methlyandrostenediol se tou kwè yo gen kèk aktivite nannan estwojèn. Li se, menm jan an tou, konsidere kòm yon fèb esoterik modera estwojèn. Gynecomastia se posib pandan tretman, men jeneralman sèlman lè pi wo dòz yo te itilize. Dlo ak retansyon grès kapab tou vin pwoblèm, ankò depann sou dòz. Moun sansib ka bezwen adisyon yon anti-estwojèn tankou Nolvadex® pou minimize efè segondè ki gen rapò.
eng
Methandriol is not directly aromatized by the body, although one of its known metabolites is methyltestosterone, which can aromatize. Methlyandrostenediol is also believed to have some inherent estrogenic activity. It is, likewise, considered a weakly to moderately estrogenic steroid. Gynecomastia is possible during treatment, but generally only when higher doses are used. Water and fat retention can also become issues, again depending on dose. Sensitive individuals may need to addition an anti-estrogen such as Nolvadex® to minimize related side effects.